Faisal Khurshid
Stock Analyst at Jefferies
(4.97)
# 82
Out of 5,081 analysts
250
Total ratings
56.1%
Success rate
65.6%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYPT EyePoint | Downgraded: Hold | $8 → $1 | $0.3657 | +173.45% | 3 | Oct 19, 2026 | |
| VCRE Vicore Pharma Holding AB | Initiated Coverage: Buy | $25 | $9.40 | +165.96% | 1 | Oct 9, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | n/a | $14.50 | - | 6 | Sep 29, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $230 → $260 | $227.66 | +14.21% | 4 | Sep 8, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $270 | $183.90 | +46.82% | 4 | Sep 3, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $290 → $330 | $245.15 | +34.61% | 3 | Aug 31, 2026 | |
| IMTX Immatics | Rated: Buy | $18 → $17 | $7.15 | +137.76% | 2 | Aug 25, 2026 | |
| INSM Insmed | Reiterated: Buy | $160 → $175 | $93.33 | +87.51% | 6 | Aug 6, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $25 | $10.48 | +138.55% | 1 | Jul 31, 2026 | |
| ONC BeOne Medicines AG | Upgraded: Buy | $333 → $380 | $370.87 | +2.46% | 3 | Jul 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $90 → $158 | $86.50 | +82.66% | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $30 | $23.34 | +28.53% | 2 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $10.00 | -20.00% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $76 → $85 | $61.07 | +39.18% | 2 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $37 | $13.22 | +179.88% | 2 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $11.03 | +90.39% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $120 | $72.60 | +65.29% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $30.91 | +77.94% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $10.34 | +45.07% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $31.28 | +5.50% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $113.31 | -17.04% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $114.84 | -4.21% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $8.14 | +157.99% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 | $89.47 | +58.71% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $12.08 | -66.89% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $25.55 | n/a | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $31.69 | n/a | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.23 | n/a | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1534 | n/a | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.45 | n/a | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.56 | n/a | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.51 | n/a | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.28 | n/a | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $140.32 | n/a | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $92.91 | n/a | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $2 | $5.54 | n/a | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.15 | n/a | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $3.50 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.8498 | n/a | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $74.58 | n/a | 1 | Jul 28, 2025 |
EyePoint
Oct 19, 2026
Downgraded: Hold
Price Target: $8 → $1
Current: $0.3657
Upside: +173.45%
Vicore Pharma Holding AB
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $9.40
Upside: +165.96%
Summit Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.50
Upside: -
Alnylam Pharmaceuticals
Sep 8, 2026
Reiterated: Hold
Price Target: $230 → $260
Current: $227.66
Upside: +14.21%
Revolution Medicines
Sep 3, 2026
Reiterated: Buy
Price Target: $270
Current: $183.90
Upside: +46.82%
Ascendis Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $290 → $330
Current: $245.15
Upside: +34.61%
Immatics
Aug 25, 2026
Rated: Buy
Price Target: $18 → $17
Current: $7.15
Upside: +137.76%
Insmed
Aug 6, 2026
Reiterated: Buy
Price Target: $160 → $175
Current: $93.33
Upside: +87.51%
Monte Rosa Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $25
Current: $10.48
Upside: +138.55%
BeOne Medicines AG
Jul 12, 2026
Upgraded: Buy
Price Target: $333 → $380
Current: $370.87
Upside: +2.46%
Jul 1, 2026
Upgraded: Buy
Price Target: $90 → $158
Current: $86.50
Upside: +82.66%
Jun 30, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $23.34
Upside: +28.53%
Jun 23, 2026
Reiterated: Buy
Price Target: $15 → $8
Current: $10.00
Upside: -20.00%
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $61.07
Upside: +39.18%
May 1, 2026
Reiterated: Buy
Price Target: $40 → $37
Current: $13.22
Upside: +179.88%
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $11.03
Upside: +90.39%
Mar 25, 2026
Reiterated: Buy
Price Target: $103 → $120
Current: $72.60
Upside: +65.29%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $30.91
Upside: +77.94%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $10.34
Upside: +45.07%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $31.28
Upside: +5.50%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $113.31
Upside: -17.04%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $114.84
Upside: -4.21%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $8.14
Upside: +157.99%
Dec 15, 2025
Reiterated: Buy
Price Target: $142
Current: $89.47
Upside: +58.71%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $12.08
Upside: -66.89%
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $25.55
Upside: n/a
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $31.69
Upside: n/a
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.23
Upside: n/a
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.1534
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.45
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.56
Upside: n/a
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $12.51
Upside: n/a
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.28
Upside: n/a
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $140.32
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $92.91
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $4 → $2
Current: $5.54
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $1.15
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $3.50
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $0.8498
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $74.58
Upside: n/a